Table 5

Factors associated with maternal peripheral blood malaria parasitaemia at delivery

FactorsMaternal parasitemiaUnivariate analysisMultivariate analysis
Total
(N=1886) n
Present
(N=54)
n (%)
Absent
(N=1832)
n (%)
cOR95% CIP valueaOR95% CIP value
Age, years
 <2563629 (53.7)607 (33.1)2.331.36 to 4.000.0021.610.80 to 3.230.18
 ≥25125025 (46.3)1225 (66.9)11
Education
 No education41810 (18.5)408 (22.3)0.980.42 to 2.250.55
 Primary29712 (22.2)285 (15.6)1.670.75 to 3.71
 Junior high68220 (37.1)662 (36.1)1.180.58 to 2.41
 High school or above48912 (22.2)477 (26.0)1
Household SES
 Most poor38216 (29.6)366 (20.0)6.761.77 to 25.770.0035.761.47 to 22.550.001
 More poor3796 (11.1)373 (20.4)2.610.60 to 11.322.350.53 to 10.34
 Poor37920 (37.1)359 (19.6)8.562.29 to 32.097.852.06 to 29.85
 Less poor36910 (18.5)359 (19.6)4.391.10 to 17.563.980.99 to 16.03
 Least poor3772 (3.7)375 (20.4)11
Marital status
 Married/married before142231 (57.4)1391 (76.0)10.00410.20
 Living together with man, unmarried2579 (16.67)248 (13.5)1.630.77 to 3.461.110.51 to 2.40
 Single, unmarried20714 (25.93)193 (10.5)3.251.70 to 6.231.970.95 to 4.08
Gravidity
 Primigravidae42519 (35.2)406 (22.2)1.991.08 to 3.670.081.120.50 to 2.510.83
 Secundigravidae46312 (22.2)451 (24.6)1.150.57 to 2.300.890.41 to 1.92
 Multigravidae99823 (42.6)975 (53.2)11
ITN use
 No66325 (46.3)638 (34.8)1.620.94 to 2.770.081.530.87 to 2.670.14
 Yes122329 (53.7)1194 (65.2)11
SP doses received
 ≤197 (5.1)6 (11.1)91 (5.0)3.401.34 to 8.640.022.841.08 to 7.430.17
 2357 (18.9)16 (29.6)341 (18.6)2.311.15 to 4.631.740.85 to 3.56
 3627 (33.2)16 (29.6)611 (33.4)1.290.65 to 2.581.260.63 to 2.55
 ≥4805 (42.7)16 (29.6)789 (43.1)11
Malaria treatment in past 2 weeks
 No166948 (88.9)1621 (88.5)10.95
 Yes2176 (11.1)211 (11.5)1.030.45 to 2.36
Malaria treatment during pregnancy
 No133529 (53.7)1306 (71.3)10.0110.01
 Yes55125 (46.3)526 (28.7)2.151.25 to 3.682.051.17 to 3.59
  • aOR, adjusted OR; cOR, crude OR; ITN, insecticide-treated bednet; SES, socioeconomic status; SP, sulphadoxine-pyrimethamine.